داروناویر (Persian Wikipedia)

Analysis of information sources in references of the Wikipedia article "داروناویر" in Persian language version.

refsWebsite
Global rank Persian rank
1st place
1st place
399th place
104th place
4th place
5th place
low place
low place
102nd place
515th place
low place
low place
low place
low place

drugs.com

  • "Darunavir". The American Society of Health-System Pharmacists. Archived from the original on 10 November 2016. Retrieved 28 November 2016.
  • "Darunavir (Prezista) Use During Pregnancy". www.drugs.com. Archived from the original on 20 December 2016. Retrieved 4 December 2016.

handle.net

hdl.handle.net

  • World Health Organization (2019). World Health Organization model list of essential medicines: 21st list 2019. Geneva: World Health Organization. hdl:10665/325771. WHO/MVP/EMP/IAU/2019.06. License: CC BY-NC-SA 3.0 IGO.

hivandhepatitis.com

mshpriceguide.org

  • "Darunavir". International Drug Price Indicator Guide. Archived from the original on 22 January 2018. Retrieved 28 November 2016.

nih.gov

aidsinfo.nih.gov

  • "Darunavir / Cobicistat". AIDSinfo. U.S. Department of Health and Human Services. Archived from the original on 3 March 2020. Retrieved 3 April 2020.
  • Guidelines for the Use of Antiretroviral Agents in HIV-1-Infected Adults and Adolescents, November 3, 2008, Developed by the DHHS Panel on Antiretroviral Guidelines for Adults and Adolescents – A Working Group of the Office of AIDS Research Advisory Council (OARAC). full guidelines بایگانی‌شده در ۲۰۰۹-۰۱-۱۳ توسط Wayback Machine.

prezista.com

web.archive.org

  • "Darunavir". The American Society of Health-System Pharmacists. Archived from the original on 10 November 2016. Retrieved 28 November 2016.
  • "Darunavir (Prezista) Use During Pregnancy". www.drugs.com. Archived from the original on 20 December 2016. Retrieved 4 December 2016.
  • "Darunavir". International Drug Price Indicator Guide. Archived from the original on 22 January 2018. Retrieved 28 November 2016.
  • "Darunavir / Cobicistat". AIDSinfo. U.S. Department of Health and Human Services. Archived from the original on 3 March 2020. Retrieved 3 April 2020.
  • Guidelines for the Use of Antiretroviral Agents in HIV-1-Infected Adults and Adolescents, November 3, 2008, Developed by the DHHS Panel on Antiretroviral Guidelines for Adults and Adolescents – A Working Group of the Office of AIDS Research Advisory Council (OARAC). full guidelines بایگانی‌شده در ۲۰۰۹-۰۱-۱۳ توسط Wayback Machine.
  • hivandhepatitis.com بایگانی‌شده در ۲۰۰۷-۰۷-۱۳ توسط Wayback Machine, Efficacy and Safety of Boosted Darunavir (Prezista) Are Superior to Lopinavir/ritonavir (Kaletra) at 96 Weeks: ARTEMIS Trial, 2008-10-28, URL بایگانی‌شده در ۲۰۰۹-۰۷-۱۹ توسط Wayback Machine.
  • hivandhepatitis.com بایگانی‌شده در ۲۰۰۷-۰۷-۱۳ توسط Wayback Machine, Darunavir (Prezista) Receives Full Traditional Approval, Dose Set for Treatment-naive Patients, Caution Urged for Pregnant Women, 2008-10-24, URL بایگانی‌شده در ۲۰۰۹-۰۵-۱۹ توسط Wayback Machine.
  • "Drug Monograph, Prezista". Archived from the original on 2016-11-11.